Home>CREON Patient Support

CREON Patient Support
and Resources

Helping your patients with EPI get the support they need

CREON provides resources and tools to help support your patients manage Exocrine Pancreatic Insufficiency (EPI) due to cystic fibrosis (CF), chronic pancreatitis (CP), pancreatectomy, or other conditions.

The CREON Doctor Discussion Guide can help patients feel more comfortable discussing their GI symptoms with you.

CREON On Course makes it easy and convenient for patients with EPI to get financial, multivitamin, and educational support.

The Bite-sized Education series contains videos that are designed to help patients learn the basics about EPI and CREON.

The CREON Treatment Tracker can help both in-person and over-the-phone patients follow up and share their progress with you.

CFCareForward provides financial, nutritional, and educational support designed for patients and caregivers of patients with cystic fibrosis (CF).

CREON patient videos offer experiences and tips from real patients who are living with EPI.

Request patient starter kits,
product samples, and more

Contact a Rep

Determine an appropriate
per-meal dose for your patients

Use Dosing Guide

Help patients learn
about EPI and CREON

View Patient Videos

Indications and Important
Safety Information

Indications¹

CREON^® (pancrelipase) Delayed-Release Capsules is a pancrelipase which is a combination of porcine-derived lipases, proteases, and amylases indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions.

Important Safety Information

Fibrosing colonopathy is associated with high-dose use of pancreatic enzyme replacement in the treatment
of cystic fibrosis patients. Exercise caution when doses of CREON exceed 2,500 lipase units/kg of body weight
per meal (or greater than 10,000 lipase units/kg of body weight per day).
To avoid irritation of oral mucosa, care should be taken to ensure that CREON is not crushed, chewed, or retained in the mouth. CREON should always be taken with food.
Porcine-derived pancreatic enzyme products contain purines. Caution should be exercised when prescribing CREON to patients with gout, renal impairment, or hyperuricemia.
There is theoretical risk of viral transmission with all pancreatic enzyme products including CREON.
Exercise caution when administering pancrelipase to a patient with a known allergy to proteins of porcine origin.
Adverse reactions that occurred in at least 2 cystic fibrosis patients (greater than or equal to 4%) receiving CREON were vomiting, dizziness, and cough.
Adverse reactions that occurred in at least 1 chronic pancreatitis or pancreatectomy patient (greater than or equal to 4%) receiving CREON were hyperglycemia, hypoglycemia, abdominal pain, abnormal feces, flatulence, frequent bowel movements, and nasopharyngitis.
CREON is not interchangeable with any other pancrelipase product.

CREON Patient Support and Resources

Helping your patients with EPI get the support they need

CREON Patient Support
and Resources